Sustainable reimbursement is key for medical artificial intelligence (AI) to benefit patients and populations at scale; however, achieving reimbursement is complex and requires the support of various stakeholders. We explain the roles of the different stakeholders and the extent to which reimbursement mechanisms, including fee-for-service and value-based care, align stakeholder interests and facilitate the scaling of medical AI adoption.
No takes yet. Share an insight, caveat, or question.
Abràmoff et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: